F
Flavo Ribichini
Researcher at University of Verona
Publications - 4
Citations - 815
Flavo Ribichini is an academic researcher from University of Verona. The author has contributed to research in topics: Fractional flow reserve & Revascularization. The author has an hindex of 4, co-authored 4 publications receiving 570 citations.
Papers
More filters
Journal ArticleDOI
Use of the Instantaneous Wave-free Ratio or Fractional Flow Reserve in PCI
Justin E. Davies,Sayan Sen,Hakim-Moulay Dehbi,Hakim-Moulay Dehbi,Hakim-Moulay Dehbi,Rasha Al-Lamee,Ricardo Petraco,Sukhjinder Nijjer,Ravinay Bhindi,Sam J. Lehman,Darren L. Walters,James Sapontis,Luc Janssens,Christiaan J. Vrints,Ahmed Khashaba,Mika Laine,E. Van Belle,Florian Krackhardt,Waldemar Bojara,Olaf Going,Tobias Härle,Ciro Indolfi,Giampaolo Niccoli,Flavo Ribichini,Nobuhiro Tanaka,Hiroyoshi Yokoi,Hiroaki Takashima,Yuetsu Kikuta,Andrejs Erglis,Hugo Vinhas,P. Canas Silva,Sérgio Bravo Baptista,Ali Alghamdi,Farrel Hellig,Bon Kwon Koo,Chang Wook Nam,Eun-Seok Shin,Joon Hyung Doh,Salvatore Brugaletta,Eduardo Alegría-Barrero,Martijn Meuwissen,Jan J. Piek,N. van Royen,Murat Sezer,C. Di Mario,Robert Gerber,Iqbal S. Malik,Andrew S.P. Sharp,Suneel Talwar,Kare Tang,Habib Samady,John D. Altman,Arnold H. Seto,J. Singh,Allen Jeremias,Hitoshi Matsuo,Rajesh K. Kharbanda,Manesh R. Patel,P. Serruys,Javier Escaned,Javier Escaned +60 more
TL;DR: Coronary revascularization guided by iFR was noninferior to revascularizations guided by FFR with respect to the risk of major adverse cardiac events at 1 year.
Journal ArticleDOI
Safety of the Deferral of Coronary Revascularization on the Basis of Instantaneous Wave-Free Ratio and Fractional Flow Reserve Measurements in Stable Coronary Artery Disease and Acute Coronary Syndromes.
Javier Escaned,Nicola Ryan,Hernán Mejía-Rentería,Christopher Cook,Hakim-Moulay Dehbi,Eduardo Alegría-Barrero,Ali Alghamdi,Rasha Al-Lamee,John D. Altman,Alphonse Ambrosia,Sérgio Bravo Baptista,Maria Bertilsson,Ravinay Bhindi,Mats Birgander,Waldemar Bojara,Salvatore Brugaletta,Christopher E. Buller,Fredrik Calais,Pedro Canas da Silva,Jörg Carlsson,Evald Høj Christiansen,Mikael Danielewicz,Carlo Di Mario,Joon Hyung Doh,Andrejs Erglis,David Erlinge,Robert Gerber,Olaf Going,Ingibjorg J. Gudmundsdottir,Tobias Härle,Dario Hauer,Farrel Hellig,Ciro Indolfi,Lars Jakobsen,Luc Janssens,Jens Jensen,Allen Jeremias,Amra Kåregren,Ann Charlotte Karlsson,Rajesh K. Kharbanda,Ahmed Khashaba,Yuetsu Kikuta,Florian Krackhardt,Bon Kwon Koo,Sasha Koul,Mika Laine,Sam J. Lehman,Pontus Lindroos,Iqbal S. Malik,Michael Maeng,Hitoshi Matsuo,Martijn Meuwissen,Chang-Wook Nam,Giampaolo Niccoli,Sukhjinder Nijjer,Hans Olsson,Sven Erik Olsson,Elmir Omerovic,Georgios Panayi,Ricardo Petraco,Jan J. Piek,Flavo Ribichini,Habib Samady,Bruce Samuels,Lennart Sandhall,James Sapontis,Sayan Sen,Arnold H. Seto,Murat Sezer,Andrew S.P. Sharp,Eun-Seok Shin,Jasvindar Singh,Hiroaki Takashima,Suneel Talwar,Nobuhiro Tanaka,Kare Tang,Eric Van Belle,Niels van Royen,Christoph Varenhorst,Hugo Vinhas,Christiaan J. Vrints,Darren L. Walters,Hiroyoshi Yokoi,Ole Fröbert,Manesh R. Patel,Patrick W. Serruys,Justin E. Davies,Justin E. Davies,Matthias Götberg +88 more
TL;DR: Overall, deferral of revascularization is equally safe with both iFR and FFR, with a low MACE rate of about 4%.
Journal ArticleDOI
Comparison of Major Adverse Cardiac Events Between Instantaneous Wave-Free Ratio and Fractional Flow Reserve–Guided Strategy in Patients With or Without Type 2 Diabetes: A Secondary Analysis of a Randomized Clinical Trial
Joo Myung Lee,Ki Hong Choi,Bon Kwon Koo,Hakim-Moulay Dehbi,Joon Hyung Doh,Chang-Wook Nam,Eun-Seok Shin,Christopher Cook,Rasha Al-Lamee,Ricardo Petraco,Sayan Sen,Iqbal S. Malik,Sukhjinder Nijjer,Hernán Mejía-Rentería,Eduardo Alegría-Barrero,Ali Alghamdi,John D. Altman,Sérgio Bravo Baptista,Ravinay Bhindi,Waldemar Bojara,Salvatore Brugaletta,Pedro Canas da Silva,Carlo Di Mario,Carlo Di Mario,Andrejs Erglis,Robert Gerber,Olaf Going,Tobias Härle,Farrel Hellig,Ciro Indolfi,Luc Janssens,Allen Jeremias,Rajesh K. Kharbanda,Ahmed Khashaba,Yuetsu Kikuta,Florian Krackhardt,Mika Laine,Sam J. Lehman,Hitoshi Matsuo,Martijin Meuwissen,Giampaolo Niccoli,Jan J. Piek,Flavo Ribichini,Habib Samady,James Sapontis,Arnold H. Seto,Murat Sezer,Andrew S.P. Sharp,Jasvindar Singh,Hiroaki Takashima,Suneel Talwar,Nobuhiro Tanaka,Kare Tang,Eric Van Belle,Niels van Royen,Hugo Vinhas,Christiaan J. Vrints,Darren L. Walters,Hiroyoshi Yokoi,Bruce Samuels,Chris Buller,Manesh R. Patel,Patrick W. Serruys,Javier Escaned,Justin E. Davies +64 more
TL;DR: The iFR- guided and FFR-guided treatment showed comparable risk of MACE and provided equal safety in selecting revascularization target among patients with diabetes.
Journal ArticleDOI
Sex Differences in Instantaneous Wave-Free Ratio or Fractional Flow Reserve–Guided Revascularization Strategy
Chee Hae Kim,Bon Kwon Koo,Hakim-Moulay Dehbi,Joo Myung Lee,Joon Hyung Doh,Chang-Wook Nam,Eun-Seok Shin,Christopher Cook,Rasha Al-Lamee,Ricardo Petraco,Sayan Sen,Iqbal S. Malik,Sukhjinder Nijjer,Hernán Mejía-Rentería,Eduardo Alegría-Barrero,Ali Alghamdi,John D. Altman,Sérgio Bravo Baptista,Ravinay Bhindi,Waldemar Bojara,Salvatore Brugaletta,Pedro Canas da Silva,Carlo Di Mario,Andrejs Erglis,Robert Gerber,Olaf Going,Tobias Härle,Farrel Hellig,Ciro Indolfi,Luc Janssens,Allen Jeremias,Rajesh K. Kharbanda,Ahmed Khashaba,Yuetsu Kikuta,Florian Krackhardt,Mika Laine,Sam J. Lehman,Hitoshi Matsuo,Martijin Meuwissen,Giampaolo Niccoli,Jan J. Piek,Flavo Ribichini,Habib Samady,James Sapontis,Arnold H. Seto,Murat Sezer,Andrew S.P. Sharp,Jasvindar Singh,Hiroaki Takashima,Suneel Talwar,Nobuhiro Tanaka,Kare Tang,Eric Van Belle,Niels van Royen,Hugo Vinhas,Christiaan J. Vrints,Darren L. Walters,Hiroyoshi Yokoi,Bruce Samuels,Christopher E. Buller,Manesh R. Patel,Patrick W. Serruys,Javier Escaned,Justin E. Davies +63 more
TL;DR: The DEFINE-FLAIR study evaluated sex differences in procedural characteristics and clinical outcomes of instantaneous wave-free ratio (iFR)- and fractional flow reserve (FFR)-guided revascularization strategies, finding that iFR- and FFR-guided strategies showed comparable clinical outcomes, regardless of sex.